Published in Diabetes on October 01, 1978
Animal models of peripheral neuropathies. Neurotherapeutics (2012) 1.09
Experimental diabetic autonomic neuropathy. Am J Pathol (1981) 1.01
Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci (2008) 0.90
Purinergic signalling and diabetes. Purinergic Signal (2013) 0.86
Lidocaine improves survival rate in diabetic rats submitted to acute left coronary artery ligation. Basic Res Cardiol (1990) 0.75
Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei. Am J Physiol Regul Integr Comp Physiol (2014) 0.75
Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci (1982) 3.02
Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol (1993) 1.92
Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. Life Sci (1986) 1.80
Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol (1990) 1.26
The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur J Pharmacol (1989) 1.24
In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther (1991) 1.24
VAMPIRE: Vessel assessment and measurement platform for images of the REtina. Conf Proc IEEE Eng Med Biol Soc (2011) 1.21
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur J Pharmacol (1989) 1.17
Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci U S A (1977) 1.16
A potent and selective agonist for NK-2 tachykinin receptor. Peptides (1989) 1.14
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase. Antiviral Res (1996) 1.09
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther (1988) 1.03
Studies in vitro of amine uptake mechanisms in heart. Biochem Pharmacol (1966) 1.03
AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther (1987) 1.00
A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. Eur J Pharmacol (1990) 0.99
Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: effect of neuromuscular blocking agents on the activity of the external urethral sphincter. J Pharmacol Methods (1991) 0.98
Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol (1986) 0.98
Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev (1995) 0.97
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors. J Auton Pharmacol (1991) 0.97
(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists. J Med Chem (1984) 0.97
Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol (1994) 0.96
In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist. Eur J Pharmacol (1993) 0.96
Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol (1991) 0.96
Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Br J Pharmacol (1992) 0.95
Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors. Gastroenterology (1992) 0.94
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium. Cell Death Differ (2006) 0.91
Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo. J Pharmacol Exp Ther (1993) 0.91
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents. Br J Pharmacol (1976) 0.91
Tachykinin receptors and intestinal motility. Can J Physiol Pharmacol (1997) 0.89
Receptor binding profile of Otilonium bromide. Pharmacol Res (1998) 0.89
The use of optical flow to characterize muscle contraction. J Neurosci Methods (2001) 0.89
Further studies on the response of the guinea-pig isolated bronchus to endothelins and sarafotoxin S6b. Eur J Pharmacol (1990) 0.89
Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Br J Pharmacol (1995) 0.88
Subsensitivity of cardiac beta-adrenoceptors in renal hypertensive rats. J Cardiovasc Pharmacol (1980) 0.88
Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.88
Tachykinin receptors in the circular muscle of the guinea-pig ileum. Br J Pharmacol (1990) 0.86
NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype. Eur J Pharmacol (1991) 0.86
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress. J Vasc Res (2004) 0.86
The possible role of ATP and PACAP as mediators of apaminsensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon. Br J Pharmacol (1996) 0.86
Motor response of the human isolated colon to capsaicin and its relationship to release of vasoactive intestinal polypeptide. Neuroscience (1990) 0.86
MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. Br J Pharmacol (1998) 0.86
Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat. J Cardiovasc Pharmacol (2000) 0.85
Effect of endothelin-1, endothelin-3 and C-terminal hexapeptide, endothelin (16-21) on motor activity in rats. Neuropeptides (1990) 0.85
NK-2 receptor agonists and antagonists. Ann N Y Acad Sci (1991) 0.85
Multiple sources of calcium for contraction of the human urinary bladder muscle. Br J Pharmacol (1989) 0.85
On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin. Biochem Pharmacol (1969) 0.85
Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. J Cardiovasc Pharmacol (1992) 0.84
The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. J Urol (1990) 0.83
Direct evidence for the involvement of vasoactive intestinal polypeptide in the motor response of the human isolated ileum to capsaicin. Eur J Pharmacol (1990) 0.83
Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J Pharmacol Exp Ther (1988) 0.83
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity. Oncogene (2011) 0.82
Modulation by stereoselective inhibition of cyclo-oxygenase of electromechanical coupling in the guinea-pig isolated renal pelvis. Br J Pharmacol (1995) 0.82
The effect of MK-801 on the micturition reflex in anesthetized rats. Eur J Pharmacol (1990) 0.82
An integrated simulator for surgery of the petrous bone. Stud Health Technol Inform (2001) 0.81
Atropine inhibits thromboxane A2 generation in isolated lungs of the guinea-pig. Br J Pharmacol (1980) 0.81
Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans. Drug Metab Dispos (1993) 0.81
Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.81
The reserpine receptor. Life Sci (1978) 0.81
Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons. Biochem Pharmacol (1966) 0.80
Effects of nucleus basolateralis amygdalae neurotoxic lesions on aversive conditioning in the rat. Physiol Behav (1991) 0.80
Role of muscarinic receptor subtypes in the regulation of migrating myoelectric complex in the dog. Gastroenterology (1989) 0.80
Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brain. Life Sci (1979) 0.80
In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist. Eur J Pharmacol (1990) 0.80
Optical specificity of monoamine oxidase. Life Sci (1966) 0.80
Facilitation of reflex micturition by intravesical administration of [beta Ala8]-neurokinin A (4-10), a selective NK-2 tachykinin receptor agonist. J Urol (1991) 0.80
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J Pharmacol Exp Ther (1993) 0.79
Effects of nucleus basolateralis amygdalae neurotoxic lesions on some spontaneous activities in the rat. Physiol Behav (1991) 0.79
Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist. Br J Pharmacol (1995) 0.79
Involvement of tachykinin NK1 receptors in plasma protein extravasation induced by tachykinins in the guinea pig upper airways. Neuropeptides (1997) 0.79
Evidence for the existence of a urethro-urethral excitatory reflex in urethane anesthetized rats: involvement of peripheral ganglionic structures. J Urol (1991) 0.79
Cimetropium: characterization of antimuscarinic and spasmolytic properties. Arzneimittelforschung (1985) 0.79
Adenylate cyclase of rat pituitary gland: stimulation by vasoactive intestinal polypeptide (VIP). FEBS Lett (1979) 0.79
Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists. Eur J Pharmacol (1995) 0.78
Pharmacological profile of mifentidine: a novel H2-receptor antagonist. Agents Actions (1985) 0.78
Pharmacological characterization of muscarinic receptors involved in McN-A-343-induced effects on intestinal motility and heart rate in conscious dogs. Br J Pharmacol (1988) 0.78
(R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptors. J Pharmacol Exp Ther (1987) 0.78
Different mechanism of tachykinin NK2 receptor blockade by SR 48968 and MEN 10,627 in the guinea-pig isolated gallbladder and colon. Eur J Pharmacol (1994) 0.78
Passive and active avoidance behavior in the light-dark box test. Physiol Behav (1984) 0.78
Evaluation of novel compounds interacting with H2-histamine receptors: effect on histamine-sensitive adenylate cyclase activity in guinea-pig gastric mucosa. Agents Actions (1985) 0.78
Pharmacology of mifentidine, a novel H2-receptor antagonist. Arzneimittelforschung (1985) 0.78
Binding of (3H)dihydroalprenolol to beta adrenoceptors of cells isolated from adult rat heart. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.77
The behavior of the homozygous and heterozygous sub-types of rats which are genetically-selected for diabetes insipidus: a comparison with Long Evans and Wistar stocks. Experientia (1991) 0.77
NK-1 receptors and vascular permeability in rat airways. Ann N Y Acad Sci (1991) 0.77
Interaction of amyloid beta protein (25-35) with tachykinin receptors. Neuropeptides (1992) 0.77
Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonists. J Med Chem (1994) 0.77
The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. Pharmacol Res (1991) 0.77
On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology (1977) 0.77
Spontaneous and conditioned behavior of Wistar and Long Evans rats. Arch Ital Biol (1987) 0.77
Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonist. J Cardiovasc Pharmacol (1995) 0.77
Intracerebroventricular administration of endothelins: effects on the supraspinal micturition reflex and blood pressure in the anaesthetized rat. Eur J Pharmacol (1991) 0.77
Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors. J Pharmacol Exp Ther (1995) 0.77
AF-DX 116 differentiates between prejunctional muscarine receptors located on noradrenergic and cholinergic nerves. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.76
Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth muscles. Neuropeptides (1992) 0.76
Studies on cytochrome b561 in amine storage granules. Biochem Pharmacol (1975) 0.76
Axoplasmic transport of noradrenaline in the sciatic nerves of spontaneously diabetic mice. Diabetologia (1979) 0.76
Intraurethral capsaicin produces reflex activation of the striated urethral sphincter in urethane-anesthetized male rats. J Urol (1993) 0.76
Microvascular leakage induced by substance P in rat urinary bladder: involvement of cyclo-oxygenase metabolites of arachidonic acid. J Auton Pharmacol (1992) 0.76
Vasoactive intestinal polypeptide (VIP) and the specific motor response to capsaicin of the human isolated ileum. Adv Exp Med Biol (1991) 0.76
In vivo and in vitro activity of SR 48,968, a non-peptide tachykinin NK-2 receptor antagonist. Regul Pept (1993) 0.76